Waters (Waters) Change In Receivables : $49 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Waters Change In Receivables?

Waters's change in receivables for the quarter that ended in Dec. 2023 was $-51 Mil. It means Waters's Accounts Receivable increased by $51 Mil from Sep. 2023 to Dec. 2023 .

Waters's change in receivables for the fiscal year that ended in Dec. 2023 was $49 Mil. It means Waters's Accounts Receivable declined by $49 Mil from Dec. 2022 to Dec. 2023 .

Waters's Accounts Receivable for the quarter that ended in Dec. 2023 was $702 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Waters's Days Sales Outstanding for the three months ended in Dec. 2023 was 78.19.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Waters's liquidation value for the three months ended in Dec. 2023 was $-2,296 Mil.

Waters Change In Receivables Historical Data

The historical data trend for Waters's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waters Change In Receivables Chart

Waters Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-22.20

37.47

-62.45

-137.87

49.18

Waters Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-98.78	44.05	6.23	50.05	-51.15

Waters Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $49 Mil.

Waters (NYSE:WAT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Waters's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	702.168	/	819.474	*	91
=	78.19

2. In Ben Graham's calculation of liquidation value, Waters's accounts receivable are only considered to be worth 75% of book value:

Waters's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	395.974	-	3476.513	+	0.75 * 702.168	+	0.5 * 516.236
=	-2,296

Waters Change In Receivables Related Terms

Thank you for viewing the detailed overview of Waters's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Waters (Waters) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (NYSE:WAT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

WAT:Mexico WAZ:Germany

Address

34 Maple Street, Milford, MA, USA, 01757

Website

https://www.waters.com

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2022, Waters generated 59% from pharmaceutical customers, 31% from industrial clients, and 10% from academic/government institutions.

Executives

Christopher A Kuebler	director	210 CARNEGIE CENTER, PRINCETON NJ 08540
Richard H Fearon	director	1239 GERBING ROAD, AMELIA ISLAND FL 32034
Edward Conard	director
Daniel J. Brennan	director	BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Mark P Vergnano	director	1007 MARKET STREET, WILMINGTON DE 19898
Gary E Hendrickson	director	1101 THIRD STREET SOUTH, MINNEAPOLIS MN 55415
John M Ballbach	director
Linda Baddour	director	PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Michael J Berendt	director
Thomas P Salice	director
Wei Jiang	director	34 MAPLE STREET, MILFORD MA 01757
Amol Chaubal	officer: SVP and Chief Financial Office	113 HARTWELL AVE, C/O QUANTERIX CORPORATION, LEXINGTON MA 02421
Jianqing Bennett	officer: SVP TA Instruments Division	34 MAPLE STREET, MILFORD MA 01757
Joann A Reed	director	C/O AMERICAN TOWER CORP, 116 HUNTINGTON AVENUE, BOSTON MA 02116
Belinda Hyde	officer: SVP, Global Human Resources	13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277